Ophthalmology · Brooklyn, NY
NPI
1669432746
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
40 W Brighton Ave Ste 103, Suite 1e
Brooklyn, NY, 11224
Phone (718) 996-2260
Groups this clinician bills Medicare through
Medicare paid, 2024
$166K
2,413 services
Medicare patients, 2024
486
Average age 77
Drug cost, 2024
$823K
3,288 prescriptions
Company payments, 2025
$1,642
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna L Bentsianov was code 92014 (ophthalmological e&m), 774 times for 372 patients. In total Anna L Bentsianov billed 2,413 services in 11 codes, and Medicare paid $166K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 774 | 372 | $110.37 | $85K |
| 92250 Angiography | Office | 590 | 441 | $30.68 | $18K |
| 92083 Vision, Hearing, and Speech Services | Office | 502 | 384 | $57.30 | $29K |
| 92202 Ophthalmological E&M | Office | 244 | 183 | $13.24 | $3,231 |
| 92012 Ophthalmological E&M | Office | 155 | 120 | $78.56 | $12K |
| 92004 Ophthalmological E&M | Office | 130 | 130 | $129.36 | $17K |
By year: 2022 $196K for 2,793 services; 2023 $171K for 2,486 services; 2024 $166K for 2,413 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anna L Bentsianov prescribed most often to Medicare patients was Azelastine Hcl, with 498 prescriptions and refills. In total Anna L Bentsianov wrote 3,288 Medicare prescriptions that cost $823K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 498 | 559 | 145 | $7,208 |
| Diclofenac Sodium Generic | 270 | 348 | 96 | $2,750 |
| Restasis Cyclosporine | 257 | 398 | 55 | $232K |
| Lumigan Bimatoprost | 226 | 350 | 44 | $93K |
| Combigan Brimonidine Tartrate/Timolol | 222 | 320 | 38 | $75K |
| Latanoprost Generic | 177 | 237 | 34 | $1,117 |
| Prolensa Bromfenac Sodium | 163 | 173 | 44 | $58K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 153 | 154 | 118 | $1,294 |
| Ilevro Nepafenac | 136 | 179 | 39 | $62K |
| Alphagan P Brimonidine Tartrate | 114 | 138 | 20 | $31K |
| Brimonidine Tartrate Generic | 108 | 157 | 24 | $12K |
| Bromfenac Sodium Generic | 104 | 107 | 20 | $25K |
| Cyclosporine Generic | 102 | 142 | 23 | $31K |
| Zerviate Cetirizine Hcl | 99 | 159 | 35 | $56K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 96 | 144 | 20 | $19K |
Brand drugs: 1,764 claims; generic drugs: 1,524 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna L Bentsianov $1,642 ($1,642 in general payments such as food, travel and fees) from 17 companies. The largest payer was Bausch & Lomb Americas Inc. with $292.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 10 | $292 |
| Harrow Eye, LLC | 10 | $267 |
| Genzyme Corporation SNY | 2 | $241 |
| Abbvie Inc. ABBV | 7 | $171 |
| Alcon Vision LLC ALC | 7 | $163 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $78.25 |
| Optinose US, Inc. | 3 | $69.22 |
| OPKO Pharmaceuticals, LLC | 3 | $63.12 |
| Mallinckrodt Hospital Products Inc. | 2 | $58.84 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $54.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.